Ex vivo fluorescence-guided resection margin assessment in breast cancer surgery using a topically applied, cathepsin-activatable imaging agent.
Linders DGJ, Bijlstra OD, Walker E, March TL, Pool M, Valentijn ARPM, Dijkhuis TH, Woltering JN, Pijl FR, Noordam G, van den Burg D, van der Sijp JRM, Guicherit OR, Marinelli AWKS, Burggraaf J, Rissmann R, Bogyo M, Hilling DE, Kuppen PJK, Straight B, Straver ME, Hazelbag HM, Basilion JP, Vahrmeijer AL.
Linders DGJ, et al. Among authors: straver me.
Pharmacol Res. 2024 Nov;209:107464. doi: 10.1016/j.phrs.2024.107464. Epub 2024 Oct 12.
Pharmacol Res. 2024.
PMID: 39401538
Free article.